BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$80.91 USD
-1.26 (-1.53%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $80.92 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 7/29/24 |
---|---|
Current Quarter | 0.61 |
EPS Last Quarter | 0.71 |
Last EPS Surprise | 18.33% |
ABR | 1.64 |
Earnings ESP
|
-6.01% |
---|---|
Current Year | 2.77 |
Next Year | 3.67 |
EPS (TTM) | 2.20 |
P/E (F1) | 29.25 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 662.23M | 689.16M | 2.72B | 3.05B |
# of Estimates | 10 | 10 | 12 | 12 |
High Estimate | 674.00M | 712.00M | 2.77B | 3.26B |
Low Estimate | 651.80M | 674.21M | 2.61B | 2.82B |
Year ago Sales | 595.28M | 581.33M | 2.42B | 2.72B |
Year over Year Growth Est. | 11.25% | 18.55% | 12.46% | 12.23% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.61 | 0.70 | 2.77 | 3.67 |
# of Estimates | 11 | 9 | 13 | 12 |
Most Recent Consensus | 0.63 | 0.67 | 2.66 | 2.93 |
High Estimate | 0.68 | 0.75 | 3.10 | 4.69 |
Low Estimate | 0.39 | 0.66 | 2.62 | 2.78 |
Year ago EPS | 0.54 | 0.46 | 2.08 | 2.77 |
Year over Year Growth Est. | 12.96% | 52.17% | 33.17% | 32.45% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 2 | 1 | 1 |
Up Last 30 Days | 1 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 3 | 3 | 3 |
Down Last 7 Days | 1 | 0 | 0 | 1 |
Down Last 30 Days | 1 | 0 | 0 | 2 |
Down Last 60 Days | 1 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.61 | 0.70 | 2.77 | 3.67 |
7 Days Ago | 0.64 | 0.69 | 2.76 | 3.71 |
30 Days Ago | 0.64 | 0.69 | 2.74 | 3.69 |
60 Days Ago | 0.64 | 0.69 | 2.73 | 3.68 |
90 Days Ago | 0.73 | 0.76 | 3.14 | 3.95 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.57 | 0.73 | 2.99 | 3.88 |
Zacks Consensus Estimate | 0.61 | 0.70 | 2.77 | 3.67 |
Earnings ESP | -6.01% | 4.29% | 7.91% | 5.92% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.71 | 0.49 | 0.46 | 0.54 | NA |
Estimate | 0.60 | 0.44 | 0.46 | 0.47 | NA |
Difference | 0.11 | 0.05 | 0.00 | 0.07 | 0.06 |
Surprise | 18.33% | 11.36% | 0.00% | 14.89% | 11.15% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more